Applied Therapeutics APLT

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.07 (+13.68%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Applied Therapeutics (APLT)
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $0.5724

  • Market Cap

    $66.60 Million

  • Price-Earnings Ratio

    -1.19

  • Total Outstanding Shares

    116.36 Million Shares

  • Total Employees

    37

  • Dividend

    No dividend

  • IPO Date

    May 13, 2019

  • SIC Description

    Pharmaceutical Preparations

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    545 fifth avenue, suite 1400, New york, NY, 10017

  • Homepage

    https://www.appliedtherapeutics.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities$23.33 Million
Net Cash Flow From Operating Activities$-23.33 Million
Net Cash Flow$0
Net Cash Flow From Financing Activities$0
Net Cash Flow From Operating Activities, Continuing$-23.33 Million
Net Cash Flow From Investing Activities, Continuing$23.33 Million

Income Statement

July 1, 2024 to September 30, 2024
MetricValue
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
Net Income/Loss Attributable To Noncontrolling Interest$0
Basic Earnings Per Share$-0.48
Revenues$122,000
Costs And Expenses$29.86 Million
Net Income/Loss$-68.59 Million

Comprehensive Income

July 1, 2024 to September 30, 2024
MetricValue
Comprehensive Income/Loss$-68.59 Million
Comprehensive Income/Loss Attributable To Parent$-68.59 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss$-68.59 Million

Balance Sheet

July 1, 2024 to September 30, 2024
MetricValue
Equity$5.89 Million
Equity Attributable To Noncontrolling Interest$0
Noncurrent Assets$1.96 Million
Current Liabilities$98.97 Million
Equity Attributable To Parent$5.89 Million
Liabilities And Equity$106.57 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about APLT from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.